Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

Emotional dysregulation is more severe among individuals with ASD than neurotypical peers and those with other clinical conditions.

The mRNA-1273 COVID-19 booster dose was safe and elicited robust immune responses among children aged 6 months to 5 years and 6 to 11 years.

Childhood attention-deficit/hyperactivity disorder (ADHD) is associated with impaired cognitive functioning in adulthood.

Influenza vaccination in successive pregnancies is not associated with increased risk for prespecified adverse perinatal outcomes.

COVID-19 vaccination was associated with a lower incidence of mental illnesses, like depression, following COVID-19 infection.